by Indigo | Feb 21, 2023 | 2023, News, Press
BELGIUM – Ghent, 21 February 2023: Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of Continuous Metabolite Monitoring (CMM®) devices utilising proprietary nanophotonics technology, today announces that that an abstract featuring its CMM®...
by Indigo | Jan 4, 2023 | 2023, News, Press
SHINE clinical trial enrolment progressing well following positive results from the GLOW early feasibility trial Several key senior appointments made in Europe and the US, reflecting the growth and evolution from an early stage to a development stage...